Novo Nordisk scales Wegovy supply amid pressure from Lilly fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Booming demand for weight loss and diabetes drugs like Ozempic, Wegovy, Mounjaro and Zepbound has vastly outpaced Novo Nordisk and Eli Lilly’s ability to produce the medication and supplies of smaller doses have been limited for months.
A cybersecurity company says it took down more than 250 websites selling fake versions of diabetes and weight-loss drugs like Ozempic in 2023. Health-care workers say it's growing problem tied to accessibly, affordability and stigma.